AMANDA SHILS: Open Payments
NPI 1740399880 · DECATUR, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$512 in 25 payments from 10 companies in 2025. Trend: 2023 $362 · 2024 $156 · 2025 $512
Food & beverage: $512
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $142 |
| Lilly USA, LLC | 4 | $85 |
| PFIZER INC. | 4 | $82 |
| Collegium Pharmaceutical, Inc. | 2 | $46 |
| Abbott Laboratories | 2 | $42 |
| Corcept Therapeutics | 2 | $41 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $20 |
| Viatris Specialty LLC | 1 | $18 |
| Novo Nordisk Inc | 1 | $16 |
Products named: BREZTRI, MOUNJARO, Jornay PM, FREESTYLE LIBRE 3, Korlym, NURTEC ODT, KISUNLA, FARXIGA.
Industry payments across IL — which companies pay providers there.
